Advancing Water Reuse Act

House Bill

H.R. 2940

119th Congress

Advancing Water Reuse Act

In Committee

Introduced:Oct 31, 2025

Primary Sponsor

Danny K. Davis

Representative

Democratic

IL-7

Cosponsors

62

Quick Stats

Policy Area

Health

Summary

This bill aims to address the growing issue of antimicrobial resistance by authorizing the government to enter into contracts with drug companies to develop and maintain a supply of critical-need antimicrobial drugs. It also provides funding for efforts to encourage the appropriate use of these drugs and track data on antibiotic resistance.

Latest Action

Referred to the Subcommittee on Health.

SponsorDanny K. Davis (D-IL)

Introduced10/31/2025

StatusReferred to the House Committee on Ways and Means.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Advancing Water Reuse Act

This bill aims to address the growing issue of antimicrobial resistance by authorizing the government to enter into contracts with drug companies to develop and maintain a supply of critical-need antimicrobial drugs. It also provides funding for efforts to enc

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill aims to address the growing issue of antimicrobial resistance by authorizing the government to enter into contracts with drug companies to develop and maintain a supply of critical-need antimicrobial drugs. It also provides funding for efforts to encourage the appropriate use of these drugs and track data on antibiotic resistance.

Bill Number: 2940
Sponsor: Danny K. Davis (D-IL)
Introduced: 10/31/2025
Status: Referred to the House Committee on Ways and Means.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Advancing Water Reuse Act
Bill Number: 2940
Sponsor: Danny K. Davis (D-IL)
Status: Referred to the House Committee on Ways and Means.
Introduced: 10/31/2025
Summary: This bill aims to address the growing issue of antimicrobial resistance by authorizing the government to enter into contracts with drug companies to develop and maintain a supply of critical-need antimicrobial drugs. It also provides funding for efforts to encourage the appropriate use of these drug

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill aims to address the growing issue of antimicrobial resistance by authorizing the government to enter into contracts with drug companies to develop and maintain a supply of critical-need antimicrobial drugs. It also provides funding for efforts to encourage the appropriate use of these drugs and track data on antibiotic resistance.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023 or the PASTEUR Act of 2023 This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $6 billion in appropriations for activities under the bill, and contains other related provisions. A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug. Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available. HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties. Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

Key Points

Main provisions of the bill

Authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts with drug companies for critical-need antimicrobial drugs
Provides $6 billion in funding for activities under the bill, including grants to support efforts to combat antimicrobial resistance
Requires HHS and the Centers for Disease Control and Prevention (CDC) to track and assess data on antibacterial resistance and human antibiotic use
Establishes a Committee on Critical Need Antimicrobials to develop a list of prioritized infections for which new antimicrobial drug development is needed
Requires the Government Accountability Office to report to Congress on the bill's effectiveness in developing priority antimicrobial drugs within six years of enactment

How This Impacts Americans

Potential effects on citizens and communities

If this bill becomes law, it would primarily impact healthcare providers, drug companies, and patients who rely on effective antimicrobial drugs. By incentivizing the development and maintenance of a supply of critical-need antimicrobial drugs, the bill aims to improve access to these important medications and help combat the growing threat of antimicrobial resistance, which can have serious health consequences for individuals and communities.

Policy Areas

Primary Policy Area

Health

Related Subjects

Administrative law and regulatory procedures

Advanced technology and technological innovations

Advisory bodies

Appropriations

Department of Health and Human Services

Drug therapy

Executive agency funding and structure

Government information and archives

Government studies and investigations

Health information and medical records

+5 more

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2940, 119th Congress (2025). "Advancing Water Reuse Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-2940

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.